Live Webcast: “1st Trimester Pre-Eclampsia Screening – Is It Worth It?”
Date: May 2 , 2024
Time: 16:00 to 18:00 CET
Our special guest speakers will explore the value and implications of early pre-eclampsia screening during the first trimester of pregnancy. By assessing the benefits, risks, and cost-effectiveness, we’ll delve into real-life experiences and whether implementing such screening protocols is justified.
Our experts:
- Prof. Jon Hyett, who will delve into “Pre-eclampsia 1st Trimester Screening: How it is Done and What is the Impact?”
- Prof. Dave Wright & Dr. Alan Wright, addressing “Risk assessment and screening for preeclampsia”
Webinar discission includes:
Screening Approaches:
- Introduction to various screening methods available during the first trimester.
- Highlighting the role of biochemical markers, ultrasound, and risk assessment as well as the value of the different inputs and how the risk calculation algorithm works.
Cost-Benefit Analysis:
- Exploration of the economic implications of implementing screening programs.
- Consideration of healthcare costs, patient outcomes, and resource allocation.
Future Directions:
- Emerging research and innovations in pre-eclampsia screening.
- Collaborative efforts to improve maternal and fetal health outcomes.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.
